Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiotaOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
Researchers compared the gastric microbiota of 54 patients with gastric carcinoma against 81 patients with chronic gastritis. They investigated whether chronic Helicobacter pylori infection and reduced acid secretion allow a distinct bacterial community to develop and drive malignancy.
How was it studied?
The gastric microbiota was profiled retrospectively using 16S rRNA gene sequencing with next-generation sequencing methods. Linear discriminant analysis effect size identified compositional differences, key taxa were validated by quantitative PCR, and PICRUSt predicted functional profiles of the communities.
What did they find?
Gastric carcinoma showed reduced microbial diversity, decreased Helicobacter abundance, and enrichment of other genera, largely intestinal commensals. A combined microbial dysbiosis index strongly discriminated carcinoma from gastritis, and functional profiling suggested a nitrosating microbial community in carcinoma; findings held across validation cohorts from different geographic origins.
Why it matters
This is the first detailed evidence that gastric carcinoma harbors a distinct dysbiotic microbiota with genotoxic potential, separate from chronic gastritis. A dysbiosis index could help distinguish malignant from non-malignant gastric disease.